![Meghna Chowdary](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Meghna Chowdary
Corporate Officer/Principal bei ARRIVENT BIOPHARMA, INC.
Aktive Positionen von Meghna Chowdary
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ARRIVENT BIOPHARMA, INC. | Corporate Officer/Principal | 01.04.2022 | - |
Karriereverlauf von Meghna Chowdary
Ehemalige bekannte Positionen von Meghna Chowdary
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
OLEMA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Ausbildung von Meghna Chowdary
Stanford University School of Medicine | Undergraduate Degree |
University of Pennsylvania | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ARRIVENT BIOPHARMA, INC. | Health Technology |
OLEMA PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Portola Pharmaceuticals LLC
![]() Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Meghna Chowdary
- Erfahrung